Marker Therapeutics

Answer: Marker Therapeutics's phone number is 17*********

Answer: Marker Therapeutics's official website is https://markertherapeutics.com

Answer: Marker Therapeutics's revenue is $25 Million to $50 Million

Answer: Marker Therapeutics's SIC: 2836

Answer: Marker Therapeutics's NAICS: 325414

Answer: Marker Therapeutics has 11-50 employees

Answer: Marker Therapeutics is in Pharmaceuticals

Answer: Marker Therapeutics contact info: Phone number: 17********* Website: https://markertherapeutics.com

Answer: We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Markers unique cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize multiple tumor associated antigens (multiTAA) and kill tumor cells expressing those targets. Once infused into patients, this population of multiTAA-specific T cells attacks multiple tumor targets and acts to activate the patients immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies.

Answer:

• Twitter
• LinkedIn